Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557

Watchlist Manager
Jiangsu Kanion Pharmaceutical Co Ltd Logo
Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557
Watchlist
Price: 14.29 CNY -4.61% Market Closed
Market Cap: 8.1B CNY
Have any thoughts about
Jiangsu Kanion Pharmaceutical Co Ltd?
Write Note

Jiangsu Kanion Pharmaceutical Co Ltd
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jiangsu Kanion Pharmaceutical Co Ltd
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557
Net Change in Cash
ÂĄ95m
CAGR 3-Years
-4%
CAGR 5-Years
-10%
CAGR 10-Years
13%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Net Change in Cash
ÂĄ3.3B
CAGR 3-Years
N/A
CAGR 5-Years
37%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Net Change in Cash
ÂĄ6.1B
CAGR 3-Years
131%
CAGR 5-Years
26%
CAGR 10-Years
45%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Net Change in Cash
ÂĄ4.4B
CAGR 3-Years
18%
CAGR 5-Years
N/A
CAGR 10-Years
13%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Net Change in Cash
ÂĄ1.6B
CAGR 3-Years
-25%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Net Change in Cash
-ÂĄ609m
CAGR 3-Years
-45%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Jiangsu Kanion Pharmaceutical Co Ltd
Glance View

Market Cap
8.3B CNY
Industry
Pharmaceuticals

Jiangsu Kanion Pharmaceutical Co., Ltd. engages in the manufacturing and sale of Chinese patent medicine preparations and health products. The company is headquartered in Lianyungang, Jiangsu and currently employs 5,045 full-time employees. The company went IPO on 2002-09-18. The firm provides capsules, oral liquid, granules, electuary, tablets, pills, patch and injections. The firm's products are applied in gynecology, orthopedics, cardiovascular and cerebrovascular, anti-infective, anti-tumor and others. The firm distributes its products mainly within domestic markets.

Intrinsic Value
23.69 CNY
Undervaluation 40%
Intrinsic Value
Price

See Also

What is Jiangsu Kanion Pharmaceutical Co Ltd's Net Change in Cash?
Net Change in Cash
95m CNY

Based on the financial report for Jun 30, 2024, Jiangsu Kanion Pharmaceutical Co Ltd's Net Change in Cash amounts to 95m CNY.

What is Jiangsu Kanion Pharmaceutical Co Ltd's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
13%

Over the last year, the Net Change in Cash growth was -91%. The average annual Net Change in Cash growth rates for Jiangsu Kanion Pharmaceutical Co Ltd have been -4% over the past three years , -10% over the past five years , and 13% over the past ten years .

Back to Top